
Sigma Healthcare Ltd
ASX:SIG

Net Margin
Sigma Healthcare Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
32.8B AUD |
0%
|
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
89B USD |
1%
|
|
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
56.5B USD |
1%
|
|
US |
![]() |
Cencora Inc
NYSE:COR
|
56.3B USD |
1%
|
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
37.6B USD |
1%
|
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
75B CNY |
8%
|
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
70.4B CNY |
2%
|
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
7%
|
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD |
3%
|
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
2%
|
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
60.3B HKD |
1%
|
Sigma Healthcare Ltd
Glance View
In the competitive landscape of Australia’s healthcare sector, Sigma Healthcare Ltd emerges as a vital cog in the country’s pharmacy and healthcare distribution wheel. Born from a humble beginning, the company has strategically evolved into one of the leading pharmaceutical wholesalers, boasting an extensive distribution network that spans across Australia's vast geography. Sigma supplies both prescription medicines and over-the-counter products to numerous independent and branded pharmacies, including recognizable names such as Amcal and Guardian. This distribution forte encapsulates Sigma’s primary revenue stream, as the company capitalizes on the efficiency of its supply chain operations, ensuring pharmaceuticals are delivered seamlessly from manufacturers directly to the doorsteps of pharmacies and hospitals. Beyond distribution, Sigma has diversified its operations to tap into retail pharmacy franchising, leveraging well-established brands to capture consumer loyalty. Operating under its banner of pharmacy brands, Sigma extends support in the form of marketing, retail advisory, and operational assistance to its franchise network, which in turn, feeds into its profitability margins. The company's strategic foresight into expanding its retail and service offerings further underpins its financial architecture, as it looks to balance its ledger not just through wholesale operations but also via the value-added services offered to its network. By orchestrating a symphony of merchandise management, supply chain prowess, and retail consultancy, Sigma Healthcare Ltd not only sustains its market relevance but also weaves itself deeply into the fabric of Australian healthcare delivery.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sigma Healthcare Ltd's most recent financial statements, the company has Net Margin of -0.3%.